DrugPatentWatch Database Preview
Drugs in MeSH Category Antineoplastic Agents
» See Plans and Pricing
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | AFINITOR | everolimus | TABLET;ORAL | 022334-002 | Mar 30, 2009 | AB | RX | Yes | No | Get Started for $10 | Get Started for $10 | Y | Get Started for $10 | ||
| Dr Reddys | IMATINIB MESYLATE | imatinib mesylate | TABLET;ORAL | 206547-001 | Aug 13, 2018 | AB | RX | No | No | Get Started for $10 | Get Started for $10 | Get Started for $10 | |||
| Novartis | AFINITOR | everolimus | TABLET;ORAL | 022334-001 | Mar 30, 2009 | AB | RX | Yes | Yes | Get Started for $10 | Get Started for $10 | Get Started for $10 | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
